Literature DB >> 11712105

Ototoxicity may be associated with protease inhibitor therapy.

B Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712105     DOI: 10.1086/324361

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  11 in total

Review 1.  Neuropsychiatric Effects of HIV Antiviral Medications.

Authors:  Glenn J Treisman; Olivia Soudry
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 2.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

3.  Highly active antiretroviral therapy: Does it Sound toxic?

Authors:  Katijah Khoza-Shangase
Journal:  J Pharm Bioallied Sci       Date:  2011-01

4.  A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve people.

Authors:  Jeffrey T Schouten; David W Lockhart; Thomas S Rees; Ann C Collier; Christina M Marra
Journal:  BMC Infect Dis       Date:  2006-02-20       Impact factor: 3.090

5.  Audiological manifestations in HIV-positive adults.

Authors:  Carla Gentile Matas; Rosanna Giaffredo Angrisani; Fernanda Cristina Leite Magliaro; Aluisio Augusto Cotrim Segurado
Journal:  Clinics (Sao Paulo)       Date:  2014-07       Impact factor: 2.365

6.  Brainstem Auditory Evoked Potential in HIV-Positive Adults.

Authors:  Carla Gentile Matas; Alessandra Giannella Samelli; Rosanna Giaffredo Angrisani; Fernanda Cristina Leite Magliaro; Aluísio C Segurado
Journal:  Med Sci Monit       Date:  2015-10-20

Review 7.  A Narrative Review of Pharmacologic Treatments for COVID-19: Safety Considerations and Ototoxicity.

Authors:  Christine Little; Maura K Cosetti
Journal:  Laryngoscope       Date:  2021-01-27       Impact factor: 2.970

Review 8.  Long-Term Effects of COVID-19.

Authors:  Shreeya Joshee; Nikhil Vatti; Christopher Chang
Journal:  Mayo Clin Proc       Date:  2022-01-12       Impact factor: 7.616

9.  Putative COVID-19 therapies imatinib, lopinavir, ritonavir, and ivermectin cause hair cell damage: A targeted screen in the zebrafish lateral line.

Authors:  Allison B Coffin; Emily Dale; Emilee Doppenberg; Forrest Fearington; Tamasen Hayward; Jordan Hill; Olivia Molano
Journal:  Front Cell Neurosci       Date:  2022-08-24       Impact factor: 6.147

10.  SARS-CoV-2 (COVID-19) and audio-vestibular disorders.

Authors:  Virginia Fancello; Stavros Hatzopoulos; Virginia Corazzi; Chiara Bianchini; Magdalena B Skarżyńska; Stefano Pelucchi; Piotr Henryk Skarżyński; Andrea Ciorba
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.